Results 1 to 10 of about 58,938 (145)

A State-of-the-Art Review Exploring the Cardiovascular Outcomes of Renin-Angiotensin Inhibitors in Acute Kidney Injury

open access: yesCardiorenal Medicine
Background: Renin-angiotensin system (RAS) inhibitors, including ACE inhibitors, ARBs, and angiotensin receptor-neprilysin inhibitors (ARNIs), are essential in managing cardiovascular and renal diseases.
Farah Yasmin   +7 more
doaj   +2 more sources

Renin inhibitors. [PDF]

open access: yesJ Clin Hypertens (Greenwich), 2011
Fisher ND, Meagher EA.
europepmc   +6 more sources

Therapeutic Implications of Renin–Angiotensin System Modulators in Alzheimer’s Dementia

open access: yesPharmaceutics, 2023
The Renin–Angiotensin System (RAS) has attracted considerable interest beyond its traditional cardiovascular role due to emerging data indicating its potential involvement in neurodegenerative diseases, including Alzheimer’s dementia (AD).
Daniela-Carmen Ababei   +8 more
doaj   +1 more source

Assessment of the effects of antihypertensive drugs in patients suffering from hypertension in Kurdistan

open access: yesAdvanced Medical Journal, 2023
Background and objectives: Hypertension is an important cardiovascular disease that carries a high rate of mortality and morbidity if not controlled. Significant complications of untreated hypertension include vascular atherosclerosis, chronic kidney ...
Mohammed Hasan Almeshhadani   +3 more
doaj   +1 more source

Development of a novel murine heart failure model overexpressing human renin and angiotensinogen

open access: yesFEBS Open Bio, 2020
Renin is the rate‐limiting enzyme of the renin–angiotensin system cascade, which drives the pathophysiological progression of heart failure. Species differences in the amino acid sequence of the catalytic domain of renin limit evaluations of the potency ...
Tomoya Hara   +6 more
doaj   +1 more source

The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients

open access: yesCells, 2020
The article describes the rationale for inhibition of the renin-angiotensin system (RAS) pathways as specific targets in patients infected by SARS-CoV-2 in order to prevent positive feedback-loop mechanisms.
Loris Zamai
doaj   +1 more source

The renin‐angiotensin‐aldosterone system, neurohumoral axis and cardiovascular mortality in LURIC

open access: yesThe Journal of Clinical Hypertension, 2022
Although neurohormones and Renin‐Angiotensin‐Aldosterone‐System (RAAS) components are important predictors of cardiovascular mortality (CVM), their importance for predicting outcomes in patients with/without RAAS‐blockers and different degrees of ...
Babak Yazdani   +9 more
doaj   +1 more source

Angiotensin-Converting Enzyme Inhibitors and Adipokines: The Role of Visfatin and Apelin in Cardiovascular Disease Management [PDF]

open access: yesالمجلة العراقية للصيدلة, 2023
Background: Angiotensin-converting enzyme (ACE) Inhibitors are medications pivotal in cardiovascular disease management, impacting the renin-angiotensin system which plays a critical role in cardiovascular health. These inhibitors not only modulate blood
Yaseen Jumaah   +2 more
doaj   +1 more source

The Use of Renin-Angiotensin System Blockades Among Patients with Chronic Kidney Disease

open access: yesAdvanced Medical Journal, 2023
Background and objectives: Hypertension is common in adult patients with chronic kidney disease with a prevalence that depends on the stage and etiology of chronic kidney disease and has been reported to range from 60-90%.
Majeed Hassan Shekhany
doaj   +1 more source

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Characteristics and Usefulness of the Direct Renin Inhibitor Aliskiren

open access: yesJournal of Pharmacological Sciences, 2010
Since renin inhibition interferes with the first and rate-limiting steps in the renin–angiotensin system, the renin step is a very attractive target for lowering blood pressure and minimizing target-organ damage.
Atsuhiro Ichihara   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy